ENTPD1 and neoplasm: In our investigation, CD39 appeared as a signature of T-Ag recognition in the peripheral of the 14 patients evaluated, which has also been reported to define tumor-specific exhausted CD8+ T cells in tumor-infiltrating lymphocytes (TIL) (35–37).